Neuromuscular Blockade: Clinical Trials

212 trials for Neuromuscular Blockade, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

146 completed, 30 unknown, 12 recruiting, 7 not yet recruiting. 62 Not applicable, 58 Phase 4, 16 Phase 3, 13 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable62Completed 38, Unknown 9, Recruiting 6, Terminated 4, Not yet recruiting 2, Active not recruiting 1, Enrolling by invitation 1, Withdrawn 1
Phase 458Completed 42, Unknown 9, Withdrawn 4, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 316Completed 12, Unknown 2, Not yet recruiting 1, Recruiting 1
Phase 213Completed 11, Unknown 2
Phase 11Completed 1

Follow Neuromuscular Blockade: new trials by email Literature Review of Neuromuscular Blockade trials Research Report on Neuromuscular Blockade

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
LIA vs. LIA + ACB-iPACK Block for Total Knee Arthroplasty
Local infiltration analgesia, Ultrasound-guided adductor canal block - Nerve Block, Neuromuscular Blockade
Not applicableNot yet recruitingWomen's College Hospital602027-01-012025-07-16
Low-Dose Rocuronium Maintenance During Spine Surgery With Intraoperative Neurophysiological Monitoring
Low-Dose Rocuronium Maintenance, Rocuronium - Spine Surgery, Intraoperative Neurophysiological Monitoring
Not applicableRecruitingBach Mai Hospital622026-10-072026-10-16
Effect of Neuromuscular Blockade on Video Laryngeal Mask Airway Ventilation
Normal Saline (Rocuronium 0 mg/kg), Rocuronium 0.3 mg/kg, Rocuronium 0.6 mg/kg - Airway Management, Neuromuscular Blockade
Phase 4Not yet recruitingKorea University Guro Hospital962026-09-072026-09-18
Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation and Bolus Maintenance in Adults
HRS-9190, Rocuronium - Neuromuscular Blockade
Phase 3RecruitingJiangsu HengRui Medicine Co., Ltd.3202026-09-022026-09-22
TetraGraph to Evaluate Onset and Recovery Times of Rocuronium
TetraGraph - Surgery, Neuromuscular Blockade
Not applicableEnrolling by invitationNationwide Children's Hospital1302026-08-252026-09-09
Acceleromyography Versus Electromyography for Neuromuscular Recovery Assessment at the End of Surgery
Simultaneous Acceleromyography and Electromyography Monitoring - Neuromuscular Blockade, Cholecystectomy
Not yet recruitingClínica Dávila702026-08-012026-07-31
Erector Spinae Block vs. Placebo Block Study
Erector spinae plane block, Placebo Block - Breast Cancer, Nerve Block
Not applicableNot yet recruitingWomen's College Hospital602026-06-012025-07-16
Effect of Sarcopenia and Frailty on Rocuronium Pharmacodynamics in Geriatric Patients
Sarcopenia, Frailty
CompletedKonya Meram State Hospital1002026-05-132026-07-28
Safety and Efficacy of HRS-9190 Compared to Cisatracurium for Continuous Intravenous Infusion in Adults
HRS-9190; under Inhalational Anesthesia, HRS-9190; under Intravenous Anesthesia, Cisatracurium (under Inhalational Anesthesia). - Neuromuscular Blockade
Phase 2CompletedJiangsu HengRui Medicine Co., Ltd.672026-04-102026-09-08
Safety and Efficacy of HRS-9190 Compared to Rocuronium for Bolus Maintenance in Adults
HRS-9190, Rocuronium - Neuromuscular Blockade
Phase 2CompletedJiangsu HengRui Medicine Co., Ltd.1032026-03-062026-05-29
Comparison of Two Quantitative EMG Monitors for Deep Neuromuscular Block in Laparoscopic/Robotic and VATS Surgery
TetraGraph (Senzime)-Guided Neuromuscular Monitoring (Dominant Hand), TwitchView (Blink)-Guided Neuromuscular Monitoring (Dominant Hand) - Neuromuscular Blockade
Not applicableRecruitingOhio State University352026-02-092026-07-15
Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation in Adults
HRS-9190 - Neuromuscular Blockade
Phase 2CompletedJiangsu HengRui Medicine Co., Ltd.702025-10-302026-01-29
Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
Rocuronium, Cisatracurium, Sugammadex - Post Operative Pulmonary Complications, Neuromuscular Blockade
Phase 4RecruitingThe University of Texas Medical Branch, Galveston4902025-08-262026-10-20
International Focus Group Discussion on Neuromuscular Monitoring.
Focus-Group discussion - Anesthesia, Neuromuscular Blockade
SuspendedUniversitair Ziekenhuis Brussel162025-07-012026-05-04
NMBA Reversal and Postoperative Urinary Retention
Choice of reversal agent (sugammadex or neostigmine [with muscaranic antagonist]) - Neuromuscular Blocking Agents, Urinary Retention After Procedure
Active not recruitingBeth Israel Deaconess Medical Center700002025-06-082026-01-23
Sarcopenia and Neuromuscular Block in Gastrointestinal Cancer Surgery
Standard Anesthesia Management - Gastrointestinal Cancer, Sarcopenia
CompletedDr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital1002025-06-012026-04-30
Skeletal Muscle Index and a Neuromuscular Blocking Agent
Neuromuscular Blockade
CompletedSeoul National University Bundang Hospital902025-05-092026-08-21
Evaluation of Neuromuscular Blockade Responses in Statin-Using and Non-Using Patients
TOF (Train-of-Four) monitoring for depth of neuromuscular blockade. - Neuromuscular Blockade, Statin-Associated Myopathy
Not yet recruitingAnkara City Hospital Bilkent1042025-02-152025-02-19
Ephedrine for Reducing Onset Time of Rocurinium in Elderly Patients
Ephedrine Hydrochloride 30 mg/ml, Saline (NaCl 0,9 %) (placebo) - Neuromuscular Blockade
Phase 4CompletedMatias Vested802025-01-132026-09-11
Abdominal Muscle Volume and a Neuromuscular Blocking Agent
preoperative computed tomography - Neuromuscular Blockade
Not yet recruitingSeoul National University Bundang Hospital902025-01-072025-01-10

Showing 20 of 212. Sign in to see all of them.

Narrower conditions

Delayed Emergence from Anesthesia (16)  ·  Postoperative Complications (7)  ·  Critical Illness (4)  ·  Pneumoperitoneum (4)  ·  Pain (3)  ·  Respiratory Distress Syndrome (3)  ·  Arrhythmias, Cardiac (2)  ·  Blood Loss, Surgical (2)  ·  Bradycardia (2)  ·  Frailty (2)  ·  Hip Fractures (2)  ·  Inflammation (2)  ·  Muscle Hypotonia (2)  ·  Pain, Postoperative (2)  ·  Renal Insufficiency (2)

Broader conditions

Pathological Conditions, Signs and Symptoms (47)  ·  Pathologic Processes (36)  ·  Signs and Symptoms (17)  ·  Postoperative Complications (16)  ·  Nervous System Diseases (14)  ·  Neurologic Manifestations (14)  ·  Respiratory Tract Diseases (9)  ·  Digestive System Diseases (7)  ·  Disease Attributes (7)  ·  Neuromuscular Manifestations (7)  ·  Urogenital Diseases (7)  ·  Female Urogenital Diseases (6)  ·  Female Urogenital Diseases and Pregnancy Complications (6)  ·  Lung Diseases (6)  ·  Male Urogenital Diseases (6)

Interventions

Sugammadex (62)  ·  Rocuronium (44)  ·  Neostigmine (34)  ·  cisatracurium (12)  ·  Glycopyrrolate (10)  ·  Atropine (8)  ·  Magnesium Sulfate (8)  ·  Neuromuscular Blockade (7)  ·  Sodium Chloride (7)  ·  Neuromuscular Blocking Agents (5)  ·  Saline Solution (5)  ·  Succinylcholine (5)  ·  Remifentanil (3)  ·  Ropivacaine (3)  ·  Dexamethasone (2)

Sponsors

Merck Sharp & Dohme LLC (15)  ·  Seoul National University Bundang Hospital (8)  ·  Seoul National University Hospital (8)  ·  Copenhagen University Hospital, Rigshospitalet (6)  ·  Herlev Hospital (5)  ·  University Health Network, Toronto (5)  ·  Christoph Czarnetzki (4)  ·  Jiangsu HengRui Medicine Co., Ltd. (4)  ·  Central Hospital, Nancy, France (3)  ·  Pontificia Universidade Catolica de Sao Paulo (3)  ·  Radboud University Medical Center (3)  ·  Technical University of Munich (3)  ·  University Hospital Ulm (3)  ·  University of Texas Southwestern Medical Center (3)  ·  Ankara University (2)

Countries

United States (43)  ·  South Korea (22)  ·  Denmark (18)  ·  China (10)  ·  France (10)  ·  Canada (9)  ·  Germany (9)  ·  Italy (9)  ·  Turkey (Türkiye) (9)  ·  Belgium (8)  ·  Brazil (7)  ·  Netherlands (7)  ·  Switzerland (6)  ·  Spain (5)  ·  Czechia (4)

Top investigators

Richard Brull, MD (4)  ·  Manfred Blobner, MD PhD (3)  ·  Tiffany Moon, MD (3)  ·  Ah-Young Oh, MD.,Ph.D. (2)  ·  Aleksandar Beric, MD (2)  ·  Brandon M Togioka, MD (2)  ·  Casper C Kjaer, MD (2)  ·  Eduardo T Moro, MD (2)  ·  Ismar L Cavalcanti, PhD (2)  ·  Jakob L Thomsen, MD (2)  ·  Kim I Albers, MD (2)  ·  Manfred Blobner, M.D. (2)  ·  Matias Vested (2)  ·  Matias Vested, MD, PhD (2)

Results publications

PMID 24240315, PMID 20595196, PMID 24977638, PMID 25125097, PMID 27405749, PMID 28044330, PMID 30130260, PMID 30985540, PMID 39453841, PMID 4037404, PMID 10201662, PMID 10449559, PMID 10754616, PMID 11465590, PMID 11748387, PMID 12456412, PMID 12638566, PMID 12943357, PMID 15519876, PMID 17307778, PMID 17312210, PMID 17561516, PMID 17562049, PMID 18603747, PMID 18635478, PMID 18769654, PMID 19194156, PMID 1952146, PMID 19713265, PMID 19919585, PMID 20234315, PMID 20442261, PMID 20523215, PMID 20592851, PMID 20592852, PMID 20601860, PMID 20683334, PMID 20851113, PMID 20876699, PMID 20885293, PMID 20996123, PMID 22183158, PMID 22732111, PMID 23344123, PMID 23452344, PMID 23461992, PMID 23573135, PMID 23851450, PMID 24121610, PMID 24305646

NIH funding

2017 (3), 2019 (2), 2008 (1), 2014 (1), U01HL123020 (1), UL1TR002378 (1)